Control Bionics is an assistive technology company developing alternative access and communication solutions for individuals with complex physical disabilities. The company focuses on enabling reliable interaction with computers and speech-generating devices for users who are unable to use traditional input methods.

Its core product, NeuroNode, is a non-invasive neural and muscle-based switch that detects intentional signals such as subtle muscle activity or neural intent to generate discrete commands. This allows users to control communication software and other assistive technologies through minimal, personalized inputs without requiring invasive procedures.

Control Bionics’ technology is deployed in clinical, rehabilitation, and home settings, supporting individuals with conditions such as ALS, spinal cord injury, and cerebral palsy. The company positions its products as practical, clinically adopted assistive infrastructure rather than experimental brain–computer interface research systems.